Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Ticagrelor Combined With ASA Versus ASA Alone in Preventing Stroke and Death in Patients With Acute Ischemic Stroke or Transient Ischemic Attack: a Randomized, Double-blind, Placebo-controlled, International Multicenter Phase III Clinical Study

NCT04962451 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT04962451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04962451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Ticagrelor Combined With ASA Versus ASA Alone in Preventing Stroke and Death in Patients With Acute Ischemic Stroke or Transient Ischemic Attack: a Randomized, Double-blind, Placebo-controlled, International Multicenter Phase III Clinical Study
Lead sponsor
Peking University Third Hospital
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2017
Completion date
October 31, 2019
Enrollment
13,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular accident, cerebrovascular accident, acute